Amrutanjan Health Care (NSE:AMRUTANJAN) Total Equity: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AMRUTANJAN Amrutanjan Health Care Ltd NSE:AMRUTANJAN
71 GF Score
Price ₹490.95
GF Value ₹830.57
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Amrutanjan Health Care Total Equity?

Amrutanjan Health Care NSE:AMRUTANJAN -0.47% 71 Total Equity is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:AMRUTANJAN with a GF Score™ of 71/100 and a GF Value™ of ₹830.57 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Amrutanjan Health Care's total equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Amrutanjan Health Care Total Equity Historical Data

* Premium members only.

The historical data trend for Amrutanjan Health Care's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amrutanjan Health Care Total Equity Chart

Amrutanjan Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,651.24 2,907.72 2,884.88 3,266.15 3,702.33

Amrutanjan Health Care Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3,420.68 0.00 3,702.33 0.00
NSE:AMRUTANJAN
71GF Score
Amrutanjan Health Care Ltd NSE:AMRUTANJAN
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amrutanjan Health Care Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Amrutanjan Health Care's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=5088.91-1386.584
=3,702

Amrutanjan Health Care's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹0 Mil mean?
Amrutanjan Health Care (NSE:AMRUTANJAN) has a Total Equity of ₹0 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Amrutanjan Health Care and its competitors.
Is Amrutanjan Health Care's Total Equity too high?
Amrutanjan Health Care's current Total Equity is ₹0 Mil. Overall, Amrutanjan Health Care has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amrutanjan Health Care's Total Equity compare to ZTS?
Amrutanjan Health Care's Total Equity of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Amrutanjan Health Care and its competitors. Amrutanjan Health Care's current Total Equity is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amrutanjan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Amrutanjan Health Care (NSE:AMRUTANJAN) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹830.57, compared to a current price of ₹490.95 — trading 40.9% below its estimated fair value. The current Total Equity is ₹0 Mil. Amrutanjan Health Care's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Amrutanjan Health Care (NSE:AMRUTANJAN), the current Total Equity is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amrutanjan Health Care (NSE:AMRUTANJAN) Overvalued in 2026?

Based on GuruFocus' analysis, Amrutanjan Health Care stock appears to be undervalued. The current stock price of ₹490.95 is trading 40.9% below its estimated GF Value™ of ₹830.57. GuruFocus considers Amrutanjan Health Care to be Significantly Undervalued.

Key valuation signals for NSE:AMRUTANJAN:

  • Total Equity: ₹0 Mil
  • GF Value™: ₹830.57 vs. price of ₹490.95 (40.9% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the NSE:AMRUTANJAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amrutanjan Health Care Business Description

Other Exchanges 590006:India
Address No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkins, and inhalers. Geographically, it generates the majority of the revenue from India.
71GF Score

Get the complete analysis for NSE:AMRUTANJAN

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹490.95
Price
₹830.57
GF Value